A person living with diabetes may walk into a consultation feeling reassured. The fasting sugars look better. The HbA1c is trending downwards On paper, diabetes looks under control.
However a doctor looking at the same report is often thinking about a different set of questions. What is the blood pressure? What are the cholesterol levels? Is there protein leaking into the urine? How good is the filtering function of the kidneys ? Has the retina been examined recently? Is there any history of unexplained breathlessness, reduced exercise capacity, or pain in the legs while walking?
Both, the doctor as well as the patient are looking at diabetes – but they are not necessarily looking at the same thing. For the patient, diabetes can easily become a disease of blood sugar numbers. Clinically, the greater concern is what years of elevated glucose may already be doing to the organs those blood vessels supply – long before a person feels anything is wrong.
The heart, kidneys, eyes and the peripheral nerves are the clearest examples. Understanding why means looking past the glucose report, at what diabetes actually does to blood vessels themselves.
What’s Really Happening Inside the Vessels
Glucose is essential fuel. The problem begins when too much of it stays in the bloodstream for too long.
In diabetes, the body either doesn’t produce enough insulin, doesn’t use it effectively, or both – so glucose accumulates in the blood. Over time, this alters proteins and tissues, raises oxidative stress and inflammation, and interferes with the “endothelium” – the delicate inner lining of blood vessels.
This matters because the endothelium isn’t just a coating. It regulates how vessels dilate and constrict, how blood flows, and how the vessel wall interacts with cholesterol, inflammatory cells and clotting factors. Once this environment is repeatedly exposed to metabolic stress, damage accumulates in both large and very small vessels – what doctors call “macrovascular” and “microvascular” disease.
The terms sound technical, but the distinction is straightforward.
Macrovascular disease affects larger arteries – the vessels coming off the aorta and their primary tributaries. Microvascular disease affects the body’s smallest vessels – essentially the arterioles and capillaries supplying the organs and nerves.
They are useful differentiation, but they should not be mistaken for two unrelated processes. It’s the same vascular system, showing damage differently depending on where and how small the vessels are. That’s where the connection between the heart, kidneys and eyes begins.
The Heart: When Diabetes Reaches the Coronary Arteries
The coronary arteries supply oxygen-rich blood to the heart muscle. When atherosclerosis develops, cholesterol-rich plaque builds up inside their walls. The arteries narrow; if a plaque ruptures and a clot blocks the vessel, a heart attack follows.
Diabetes accelerates this. More importantly, coronary disease in diabetic patients tends to be more extensive and diffuse – often involving several arteries rather than one isolated blockage. That single fact changes how doctors decide whether to treat with medication, a stent, or bypass surgery. Infact, even before there is discernable deposition of cholesterol within the intimal layer of the coronary arteries, there is a stagnation of flow within the coronary circulation which can cause microvascular angina, but with a normal coronary angiogtram.
Coronary disease is only half the picture. Diabetes also raises the risk of heart failure – a heart that no longer pumps or fills as effectively as the body needs. Diastolic dysfunction or failure of the ventricles to relax properly is commonly seen. This can follow a heart attack, but diabetes can weaken the heart muscle directly(diabetic cardiomyopathy), through changes in metabolism, blood pressure and circulation, even without a heart attack.
This is why a cardiac assessment in a diabetic patient can’t stop at “are the arteries blocked?” Kidney function, blood pressure, and the overall burden of vascular disease all shape what treatment is appropriate and how well a patient will tolerate it.
The coronary angiogram reveals the arteries of the heart but it doesn’t reveal the entire picture of the patient’s health .
The Kidneys: Damage That Begins Quietly
If the heart shows what diabetes does to large arteries, the kidneys show what happens at the microscopic level.
Each kidney contains roughly a million tiny filtering units called nephrons, built around microscopic vessel clusters called glomeruli. Blood passes through these filters continuously, removing waste while retaining what the body needs.
Diabetes can damage this filtration system gradually – and the first sign is rarely kidney failure. Often, it’s simply that “albumin”, a protein that should stay in the bloodstream, begins leaking into the urine. This is albuminuria, and it can appear before filtration itself has measurably declined – meaning kidney injury can be underway before a patient feels anything at all.
Two measurements matter here:
eGFR(estimated glomerular filtration rate), which estimates how well the kidneys are filtering, and
UACR (urine albumin-to-creatinine ratio), which catches early albumin leakage. Relying on serum creatinine alone can miss this window entirely.
The relationship also runs both ways. Once kidney disease develops, it independently raises cardiovascular risk – a metabolic problem becomes a kidney problem, and the kidney problem adds further strain back onto the heart.
The Eyes: What Tiny Vessels Reveal
The retina holds one of the body’s most intricate networks of small blood vessels, which makes it especially vulnerable to prolonged high glucose.
As these vessels are damaged, tiny bulges called microaneurysms appear. Vessels may leak blood or fluid; some areas of the retina may be starved of oxygen. If this progresses, the retina responds by growing new vessels – fragile ones, prone to bleeding – while fluid can pool in the macula, the part responsible for sharp central vision. This is diabetic macular edema, part of the broader process of diabetic retinopathy.
The dangerous part: this can all happen while vision still looks completely normal. A retinal exam matters precisely because eyesight is often the last thing to change, not the first.
Diabetic peripheral neuropathy
Decreased blood supply to the nerves results in starts off as tingling, burning or sharp shooting pains in the toes or numbness and reduced sensation to temperature changes on the hands and feet with muscle weakness and loss of balance and coordination.
These Organs Don’t Get Sick Independently
Medicine is organized into specialties because expertise demands it. The cardiologist looks at the heart, the nephrologist at the kidneys, the ophthalmologist at the retina. Diabetes doesn’t recognize those boundaries – the patient has a single, interconnected vascular network.
Coronary disease, albuminuria,peripheral neuropathy and retinal changes in the same person aren’t three coincidental diagnoses. They’re the same underlying vascular stress, expressed in three different organs. And the relationship compounds: kidney dysfunction makes blood pressure and fluid control harder and raises cardiac risk; heart failure strains kidney function; hypertension accelerates damage to both kidneys and retina.
This overlap is now significant enough to have its own name. Cardiologists and researchers increasingly refer to cardiovascular-kidney-metabolic (CKM) syndrome – a deliberate move away from treating diabetes, kidney disease and heart disease as separate silos. The organ in front of you often can’t be fully understood without looking at the others.
Two More Systems Worth Watching
The heart, kidneys and eyes aren’t the only vascular territories at risk.
Large-vessel disease can reach the brain, raising stroke risk, or the legs, causing peripheral artery disease – often felt first as pain while walking. Diabetes induced poor circulation causes ulcers and slow healing occur together – a small foot wound can turn into a serious clinical problem like peripheral gangrene quickly.
Not everyone with diabetes develops these complications. But diabetes is best understood as a disease capable of affecting multiple vascular territories at once – not as a single abnormal lab value.
Why a Good HbA1c Isn’t the Whole Story
None of this makes HbA1c less important. Glucose control remains fundamental to reducing complication risk.
But HbA1c only answers one question: what has average blood glucose been over the past few months? It doesn’t show whether albumin has started leaking through the kidneys. It doesn’t reveal coronary plaque forming. It doesn’t measure blood pressure or catch early retinal change. And it won’t tell you whether the heart muscle itself is beginning to weaken.
That’s why modern diabetes care increasingly treats organ protection as a goal in itself, alongside glucose control – factoring in blood pressure, cholesterol, kidney function, weight and physical activity. Even prescribing habits reflect this: certain diabetes medicines, including SGLT2 inhibitors and GLP-1 receptor agonists, are now used as much for their proven heart and kidney protective effects as for lowering glucose.
The real question has shifted from “how low is the blood sugar?” to “how well are we protecting this patient from what diabetes can eventually do?” That’s a far more meaningful measure of control.
A Few Questions Worth Raising at Your Next Visit
If you live with diabetes, it may be worth asking your doctor:
- What is my eGFR and UACR, and when were they last checked?
- When did I last have a fundoscopy (dilated pupil) examination of my retina?
- What is my current blood pressure and cholesterol target, given my diabetes?
- Am I on any medication chosen specifically to protect my heart or kidneys – not just my glucose?
None of these require alarm. They simply shift the conversation from one number to the fuller picture underneath it.
Blood glucose is easy to measure. Organ damage is often much quieter – which is exactly why it deserves equal attention.
Should “good diabetes control” still begin and end with HbA1c – or is it time organ protection became just as familiar a part of that conversation?
I’d be curious how other clinicians, and patients managing this daily, would answer that.
